Kreon

Pancreas Powder, the active ingredient in Kreon, is a pancreatic enzyme presented as a powder for oral solution for oral use. It provides exogenous enzymes to aid digestion in patients with exocrine pancreatic insufficiency, cystic fibrosis, or chronic pancreatitis. The formulation is designed to be reconstituted with water and taken with meals to maximize nutrient absorption.

GNH USA supplies Kreon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide and procurement teams across multiple regions with reliable delivery.

Kreon is used to replace deficient pancreatic enzymes in conditions that impair digestion. - Exocrine pancreatic insufficiency: improves digestion of fats, proteins and carbohydrates by supplying necessary enzymes. - Cystic fibrosis: enhances nutrient absorption and reduces steatorrhea by providing pancreatic enzymes. - Chronic pancreatitis: supports digestive function and mitigates malabsorption in patients with chronic pancreatic damage.

Kreon may be associated with several adverse reactions, most of which are mild and related to the gastrointestinal tract.

Common Side Effects: - Abdominal discomfort: mild pain or cramping after dosing. - Diarrhea: loose stools occurring during treatment. - Nausea: feeling of sickness without vomiting. - Flatulence: increased intestinal gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Allergic reaction: rash, itching, swelling, or anaphylaxis. - Pancreatitis: new or worsening pancreatic inflammation. - Fibrosing colonopathy: rare colonic fibrosis with high‑dose, long‑term use. - Severe abdominal pain: persistent or worsening pain requiring medical attention.

Before prescribing Kreon, clinicians should consider several precautionary measures to ensure safe use. - Assess pancreatic function: confirm diagnosis of enzyme deficiency before initiating therapy. - Adjust dose with meals: advise patients to take the reconstituted solution with each main meal and snack. - Monitor nutritional status: regularly evaluate weight, vitamin levels and stool fat content. - Watch for allergic history: avoid use in patients with known hypersensitivity to porcine proteins. - Review concomitant acid‑suppressive therapy: proton pump inhibitors may reduce enzyme activity and may require dose adjustment. - Store below 25°C: keep in the original container, protect from moisture and heat.

Kreon can interact with other medicines, affecting either its efficacy or the safety of the co‑administered drug.

Major Interactions (Avoid): - Proton pump inhibitors: may significantly reduce enzyme activity, compromising digestion. - Antacids containing aluminum or magnesium: can bind enzymes and lower their effectiveness.

Moderate Interactions (Monitor Closely): - Lipid‑lowering agents (e.g., orlistat): may interfere with fat digestion and alter absorption of both drugs. - Antibiotics such as tetracycline: reduced absorption due to binding with calcium in the formulation. - Warfarin: monitor INR as changes in vitamin K absorption may affect anticoagulation.